ELDN

Eledon Pharmaceuticals Inc

NASDAQ: ELDN · HEALTHCARE · BIOTECHNOLOGY

$3.88

-6.12% today

Updated 2026-06-02

Market cap

$263.21M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-0.77

Dividend yield

—

52W range

$1 – $5

Volume

1.4M

Market cap

$263.21M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-0.77

Dividend yield

—

52W range

$1 – $5

Volume

1.4M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

6.0

Quality

3.0

Profitability

5.0

Valuation

C+

1/9

Piotroski F-Score

Weak

-2.8

Altman Z-Score

Distress

—

Industry rank

—

View all highly rated stocks (75+) →202 stocks currently score above 75

Price targets

Analyst target

$8.20

+111.34%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

0 Strong Buy7 Buy0 Hold0 Sell0 Strong Sell

Price chart

Stock snapshot

Strengths

+ Debt/equity 0.01x — low leverage

Risks

- Piotroski 1/9 — weak financial health

- Altman Z -2.83 — distress zone

- Thin margins at 0.00%

- Negative free cash flow $-22.61M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-87.97M	$-40.33M	$-36.18M	$-45.62M	$-39.02M
EPS	—	—	—	—	$-0.77
Free cash flow	$-28.42M	$-39.53M	$-47.27M	$-62.34M	$-22.61M
Profit margin	—	—	—	—	—

Recent insider activity

Date	Insider	Type	Shares	Price
2035-01-10	ROBINSON, JAMES A. JR.	Buy	30,870	—
2026-01-10	ROBINSON, JAMES A. JR.	Sale	3,430	—
2026-01-10	ROBINSON, JAMES A. JR.	Buy	3,430	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
ELDN	$263.21M	20	4.3	3.0	5.0	6.0	—	Avoid
LLY	$948.95B	78	10.0	10.0	5.0	6.0	—	Strong Buy
JNJ	$536.54B	59	4.7	9.0	3.3	6.0	-71.41%	Buy
ABBV	$380.57B	63	4.0	8.0	4.0	5.0	-55.64%	Buy
UNH	$343.21B	54	5.3	5.5	4.7	5.5	-26.61%	Buy
MRK	$285.64B	50	3.3	8.0	2.7	5.0	-49.34%	Hold

Smart narrative

Eledon Pharmaceuticals Inc trades at $3.88. Our Smart Value Score of 20/100 indicates the stock is weak. The company scores 1/9 on the Piotroski F-Score. With an Altman Z-Score of -2.83, it sits in the distress.

Frequently asked questions

What is Eledon Pharmaceuticals Inc's stock price?

Eledon Pharmaceuticals Inc (ELDN) trades at $3.88.

Is Eledon Pharmaceuticals Inc overvalued?

Eledon Pharmaceuticals Inc carries a Smart Value Score of 20/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.

What is the price target of Eledon Pharmaceuticals Inc (ELDN)?

The 12-month analyst consensus target is $8.20, about 111.3% above the current $3.88. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.

Altman Z-Score?

Eledon Pharmaceuticals Inc's Altman Z-Score is -2.83, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio—

ROE-77.79%

Beta0.97

50D MA$3.53

200D MA$2.67

Shares out0.08B

Float0.07B

Short ratio—

Avg volume1.4M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

ELDN vs LLY →ELDN vs JNJ →ELDN vs ABBV →Stock screener →